Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection

Circulation Journal

Volumn 72, Issue 11, 2008, Pages 1758-1761

  Takeshita, Satoshi ^a,c   Sakamoto, Shingo ^a   Kitada, Shuichi ^a   Akutsu, Koichi ^a   Hashimoto, Hideki ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Aneurysmal dilatation; Antihypertensive drugs; Aortic dissection

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ACUTE DISEASE; ACUTE TYPE B AORTIC DISSECTION; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; AORTA ANEURYSM; AORTA DISSECTION; AORTA RUPTURE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LIMB ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK REDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTIC RUPTURE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS;

EID: 55449131314     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0466     Document Type: Article

References (17)

1. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): New insights into an old disease. JAMA 2000; 283: 897-903.
2. Akutsu K, Nejima J, Kiuchi K, Sasaki K, Ochi M, Tanaka K, et al. Effects of the patent false lumen on the long-term outcome of type B acute aortic dissection. Eur J Cardiothorac Surg 2004; 26: 359-366.
3. Neya K, Omoto R, Kyo S, Kimura S, Yokote Y, Takamoto S, et al. Outcome of Stanford type B acute aortic dissection. Circulation 1992; 86(Suppl): II-1-II-7.
4. Glower DD, Fann JI, Speier RH, Morrison L, White WD, Smith LR, et al. Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. Circulation 1990; 82(Suppl): IV-39-IV-46.
5. Genoni M, Paul M, Tavakoli R, Kunzli A, Lachat M, Graves K, et al. Predictors of complications in acute type B aortic dissection. Eur J Cardiothorac Surg 2002; 22: 59-63.
6. Sueyoshi E, Sakamoto I, Hayashi K, Yamaguchi T, Imada T. Growth rate of aortic diameter in patients with type B aortic dissection during the chronic phase. Circulation 2004; 110(Suppl 1): II-256-II-261.
7. Glower DD, Speier RH, White WD, Smith LR, Rankin JS, Wolfe WG. Management and long-term outcome of aortic dissection. Ann Surg 1991; 214: 31-41.
8. Hata M, Sezai A, Niino T, Yoda M, Wakui S, Unosawa S, et al. Prognosis for patients with type B acute aortic dissection: Risk analysis of early death and requirement for elective surgery. Circ J 2007; 71: 1279-1282.
9. Sakakura K, Kubo N, Ako J, Ikeda N, Funayama H, Hirahara T, et al. Determinants of in-hospital death and rupture in patients with a Stanford B aortic dissection. Circ J 2007; 71: 1521-1524.
10. Liao S, Miralles M, Kelley BJ, Curci JA, Borhani M, Thompson RW. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001; 33: 1057-1064.
11. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: A population-based case-control study. Lancet 2006; 368: 659-665.
12. Genoni M, Paul M, Jenni R, Graves K, Seifert B, Turina M. Chronic β-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg 2001; 19: 606-610.
13. Onitsuka S, Akashi H, Tayama K, Okazaki T, Ishihara K, Hiromatsu S, et al. Long-term outcome and prognostic predictors of medically treated acute type B aortic dissections. Ann Thorac Surg 2004; 78: 1268-1273.
14. Tham DM, Martin-McNulty B, Wang YX, Da Cunha V, Wilson DW, Athanassious CN, et al. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol 2002; 283: R1442-R1449.
15. Claridge MW, Hobbs SD, Quick CR, Day NE, Bradbury AW, Wilmink AB. ACE inhibitors increase type III collagen synthesis: A potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 2004; 28: 67-70.
16. Ahimastos AA, Natoli AK, Lawler A, Blombery PA, Kingwell BA. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 2005; 45: 1194-1199.
17. da Cunha V, Tham DM, Martin-McNulty B, Deng G, Ho JJ, Wilson DW, et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005; 178: 9-17.